Trial NCT01310803

View at ClinicalTrials.gov 
Org. Study IDs: EN3329-301

Last trial update was posted on 2017-10-05

MeSH Interventions

Valrubicin

MeSH Conditions

Carcinoma Carcinoma in Situ Carcinoma, Transitional Cell Non-Muscle Invasive Bladder Neoplasms

Other Conditions

Non-muscle Invasive Bladder Cancer Transitional Cell Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

This study was terminated early. Only one subject was enrolled. No study results were generated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID